EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition.

EphB2, a receptor tyrosine kinase for ephrin ligands, is overexpressed in various cancers and plays an important role in tumor progression. However, the expression and functions of EphB2 in cervical cancer remain unknown. In this study, we performed immunohistochemistry in clinical cervical specimens and found that EphB2 was overexpressed in the cervical cancer specimens, and its expression correlated with cancer progression. The percentage of EphB2-positive cells increased gradually from 28% in the normal cervix to 40% in high-grade squamous intraepithelial lesions, and ultimately to 69.8% in squamous cell carcinomas (P < .05). We overexpressed EphB2 in HeLa cells and silenced EphB2 in cervical cancer (C33A) cells, which expressed low and high levels of EphB2, respectively. Exogenous EphB2 promoted cell migration, invasion, and an epithelial-mesenchymal transition (EMT) signature, which is a complex process that occurs during organogenesis and cancer metastasis, whereas EphB2 silencing had the opposite effect (P < .05). Furthermore, HeLa cells with exogenous EphB2 exhibited a stem cell-like state that promoted tumorsphere formation in vitro and exhibited tumorigenesis potential in vivo (P < .05), whereas EphB2 silencing in C33A cells inhibited these stem cell properties (P < .05). In addition, we investigated the intracellular signaling pathways in cervical cancer and found that R-Ras expression correlated positively with EphB2 in clinical samples, and its activity was regulated by EphB2 in cervical cancer. These findings demonstrate that EphB2 plays an important role in cervical cancer progression by orchestrating an EMT program through R-Ras activation.

[1]  K. Basso,et al.  Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes , 2007, Genes, chromosomes & cancer.

[2]  Suet Yi Leung,et al.  Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors , 2007, Proceedings of the National Academy of Sciences.

[3]  Tony Pawson,et al.  β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinB , 2002, Cell.

[4]  Tian-qi Wang,et al.  Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma. , 2012, Gynecologic oncology.

[5]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[6]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[7]  M. Nieto,et al.  Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. , 2009, The Journal of clinical investigation.

[8]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[9]  T. Deng,et al.  Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. , 2007, Cancer research.

[10]  M. Bienz.  Faculty Opinions recommendation of Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. , 2002 .

[11]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[12]  M. Malumbres,et al.  The TGF-beta co-receptor endoglin modulates the expression and transforming potential of H-Ras. , 2010, Carcinogenesis.

[13]  K. Kullander,et al.  Mechanisms and functions of eph and ephrin signalling , 2002, Nature Reviews Molecular Cell Biology.

[14]  Wenjun Guo,et al.  Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State , 2012, Cell.

[15]  L. Tran,et al.  Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells. , 2012, Cancer research.

[16]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[17]  C. Pérez-Plasencia,et al.  Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance , 2012, BMC Cancer.

[18]  E. Ruoslahti,et al.  An Eph receptor regulates integrin activity through R-Ras. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Cu Nguyen,et al.  Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression. , 2009, Cancer research.

[20]  Jennifer S. Yu,et al.  Inflammation and Hras signaling control epithelial-mesenchymal transition during skin tumor progression. , 2013, Genes & development.

[21]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[22]  M. Cronauer,et al.  Overexpression of p16INK4a in Urothelial Carcinoma In Situ Is a Marker for MAPK-Mediated Epithelial-Mesenchymal Transition but Is Not Related to Human Papillomavirus Infection , 2013, PloS one.

[23]  B. Kong,et al.  Low-dose radiation-induced epithelial-mesenchymal transition through NF-κB in cervical cancer cells. , 2013, International journal of oncology.

[24]  P. Vaupel,et al.  Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix , 2013, British Journal of Cancer.

[25]  J. Hamada,et al.  Role of Eph/ephrin tyrosine kinase in malignant glioma. , 2011, Neuro-oncology.

[26]  S. Pecorelli,et al.  Revised FIGO staging for carcinoma of the cervix , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[27]  Yanlin Wang,et al.  Up-regulated miR155 Reverses the Epithelial-mesenchymal Transition Induced by EGF and Increases Chemo-sensitivity to Cisplatin in Human Caski Cervical Cancer Cells , 2012, PloS one.

[28]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[29]  Mitsutoshi Nakada,et al.  EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion. , 2005, The American journal of pathology.

[30]  M. Berens,et al.  The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. , 2004, Cancer research.

[31]  B. Bao,et al.  Activated K‐Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype , 2013, Journal of cellular physiology.